One step closer to controlling LDL-c levels in HoFH with PCSK9i - PACE-CME

One step closer to controlling LDLc levels in HoFH with PCSKi

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Mechanistic underpinning of CV benefit observed with icosapent ethyl
Mechanistic underpinning of CV benefit observed with icosapent ethyl
ACC 2020
Mechanistic underpinning of CV benefit observed with icosapent ethyl
- Deepak Bhatt, MD
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
ACC 2020
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
- Prof. Freek Verheugt, MD
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
ACC 2020
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
- Prof. Frederick Raal
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
ACC 2020
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
- Dr. Jur ten Berg